Danderyd, 2012-01-02 16:06 CET (GLOBE NEWSWIRE) -- XCounter AB (publ)
PRESS RELEASE
Stockholm, 2 January 2012
Changes in major shareholding
XCounter AB (Nasdaq OMX First North: XCT) ("XCounter" or the “Company”), a technology leader in the development and supply of specialty X-ray detectors, announces that as of today XR Invest AS has increased its shareholding to 25.12 per cent by holding 982,124 shares.
XR Invest AS used their call option with Acrorad CO Ltd and acquired 174,406 shares, equaling 4.46 per cent of total outstanding shares and votes. Jean-Philippe Flament is Board Director at XR Invest AS.
For further information, please contact:
| XCounter AB | |
| Fredrik Henckel – CEO | +46 (0) 8 622 2317 |
|
Jean-Philippe Flament – Chairman |
+33 680 869 787 |
| Mangold Fondkommission (Certified advisor & Liquidity Provider | +46 (8) 5030 1550 |
| Erik Josefsson | |
About XCounter AB
XCounter AB is a leader in the development and supply of direct conversion, photon counting and tomosynthesis based 3D X-ray imaging technologies for medical, dental and industrial X-ray imaging. The Company recently delisted from AIM London and relisted to Nasdaq OMX First North.
Headquartered in Stockholm, XCounter employs 32 people in its facilities in Sweden and Finland. For more detailed information, please visit: www.xcounter.se
